 |
|
|
|
 |
|
|
| Article 1 to 7 out of 7 concerning Astellas Pharma Inc.
|
-
MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies
(02/26/2008)
MorphoSys AG announced that Astellas Pharma Inc. has decided to extend the current collaboration between the two companies. The collaboration, originally signed in March 2007, will now run its full term. Under the agreement, which is now extended ...
-
Kirin and Astellas Enter Into Licensing Agreement on Immunosuppressive Fully Human Monoclonal Antibody
(01/26/2007)
Kirin Brewery Company, Limited and Astellas Pharma Inc. announced that they have entered into a license and collaborative research and development agreement under which Kirin and Astellas will exclusively collaborate in developing and marketing a ...
-
Closure of Astellas CNS research in Edinburgh
(04/25/2006)
Astellas Pharma Inc. has announced that it decided not to continue its Astellas CNS research in Edinburgh following the expiration of the third-phase joint research agreement with the University of Edinburgh in March 2007.Astellas concluded a ...
-
Dynogen Research Operation Aquired by Astellas Pharma Inc.
(03/03/2006)
Dynogen Pharmaceuticals, Inc. and Astellas Pharma, Inc. announced that Astellas has acquired Dynogen's North Carolina-based research facility. Financial details regarding the sale were not disclosed. The research facility specializes in ...
-
Astellas Has Established Astellas Venture Management in the US
(01/30/2006)
Astellas Pharma Inc. announced that it has established Astellas Venture Management LLC, a company managing venture investment business into emerging biotech companies that are dedicated to developing new pharmaceutical seeds, or constructing a new ...
-
Collaborative Search for Microorganisms in Vietnam
(11/03/2005)
The National Institute of Technology and Evaluation (NITE), Astellas Pharma Inc. and Chugai Pharmaceutical Co., Ltd. will start the first industry-government collaborative research program in November to jointly search, collect and isolate ...
-
Astellas Announces Dissolution of Astellas Systems
(11/01/2005)
Astellas Pharma Inc. announced that Astellas and Fujitsu Limited agreed to transfer the operation of information systems which has been handled by Astellas Systems Co., Ltd., a wholly owned subsidiary of Astellas, to Fujitsu. Following this ...
|
|
|
|
|
Top